ClinicalTrials.gg
Active, not recruitingNCT06479707Updated Jul 2, 2026

Digital Literacy Intervention to Address Support, Literacy and Communication in Older Adults

An interventional study of Digital Literacy Intervention in Quality of Life, Aging and Technology, sponsored by Johns Hopkins University. Active, not recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-07-02.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Study summary

The investigators propose a person-directed, values-based digital literacy intervention to address the community-identified barriers of health literacy, health communication and social support to improve quality of life and specific disease related metrics in the older adult's own home. This intervention will be a way to address the community-identified barriers of health literacy, health communication and social support to improve quality of life and specific disease related metrics in the older adult's own home.

Read the detailed description

This is a one-arm pilot trial to test the feasibility and acceptability of the intervention Digital Literacy Pilot Intervention to Address Support, Literacy and Communication in Older Adults. Each participant will receive 4-6 home visits with 3-4 interim phone calls based on the participant's individual digital literacy needs and goals. Each participant will receive internet connectivity (if not already available), a tablet (if not already available) and tailored action plans co-developed by the participant and the interventionist. In each participant will also have pre and post-intervention visits with the research team.

In earlier phases, research team members conducted preliminary activities to design the intervention using Human-Centered Design techniques.

02

Conditions studied

  • Quality of Life
  • Aging
  • Technology
  • Literacy

Browse trials for

Keywords

  • Literacy
  • Digital
  • Intervention
  • Older Adults
  • Technology
03

In context

Literacy

201 studies on the registry are indexed under Literacy; 69 are open to participants now.

This study's planned enrollment of 20 is below the median of 124 across 170 interventional studies indexed under Literacy.

Browse Literacy studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,815 studies on the registry; 315 are open to participants now.

Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 65 years old or older
  • English proficient
  • Willingness to improve digital literacy

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment as defined by a 6-item Callahan Cognitive Screener
  • Hospitalization overnight more than 3 times in the last 12 months by self-report.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Other
    Pilot

    Behavioral: Digital Literacy Intervention

Interventions

  • BehavioralDigital Literacy Intervention

    This intervention consists of 4-6 home visits with 3-4 interim phone calls based on the participant's individual digital literacy needs and goals. Each participant will receive internet connectivity (if not already available), a tablet (if not already available) and tailored action plans co-developed by the participant and the interventionist.

06

What researchers measure

Primary outcomes

  1. Change in Health Team Communication as assessed by the CollaboRATE Scale Measure

    The CollaboRATE scale measure is a 3 item self-report questionnaire on patient's shared decision making. It is scored on a 10-point anchored scale, ranging from 0 ("no effort was made") to 9 ("every effort was made"). Higher scores indicate more shared decision making.

    Time frame: Baseline, 9 weeks

  2. Change in self-efficacy as assessed by the Coping Self-Efficacy Instrument

    Coping Self-Efficacy is a 13 item instrument on a scale of 0 ('can't do at all') to 10 ('certain can do'). A higher score indicates higher level of self-efficacy when implementing coping strategies. Score range 0-130.

    Time frame: Baseline, 9 weeks

  3. Change in self-efficacy as assessed by the Self-Efficacy of Chronic Disease Management Instrument

    Self-Efficacy of Chronic Disease Management Instrument is a 6 item instrument on a visual analog scale, ranging from 1 (not at all confident) to 10 (totally confident). Lower scores indicate lower self-efficacy as indicated by confidence. Score range 6-60.

    Time frame: Baseline, 9 weeks

  4. Change in Social engagement as assessed by the Lubben Social Network Scale

    The Lubben Social Network Scale is a 7-item questionnaire that measures the size of social networks of family and friends. The score ranges between 0 and 30, with higher scores indicated more social engagement.

    Time frame: Baseline, 9 weeks

  5. Change in Social engagement as assessed by the Krause-Borawski-Clark Support Interactions Scale

    The Krause-Borawski-Clark Support Interactions Scale is a 10-item self-reported questionnaire that measures social interactions. The scale is broken down into different domains; scores range from very often (4); fairly often (3); once in a while (2); never (1) or binary-- satisfied (1) or not satisfied (0) depending on domain within the questionnaire. Items are summed to form a single composite score range 10-40, Higher scores on the scale is associated with better personal perception and social support.

    Time frame: Baseline, 9 weeks

  6. Change in quality of life as assessed by the European Quality of Life (Euro-QOL-5D)

    The Euro-QOL-5D is a self-report measure that measures quality of life across 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Response choices are severe, moderate or none (levels of disability) across domains. Questionnaire also includes a Visual Analog Scale, where respondents report their perceived health status ranging from 0 (the worst possible health status) to 100 (the best possible health status).

    Time frame: Baseline, 9 weeks

  7. Change in health literacy as assessed by the Rapid Estimate of Adult Literacy in Medicine (REALM)

    The REALM screening tool assesses ability for respondent to correctly pronounce a list of common medical words and lay terms using the REALM Patient Word List. A score of 0-18 is 3rd grade and below, score of 19-44 is 4th to 6th grade, score of 45-60 is 7th to 8th grade, and a score of 61-66 is high school or above.

    Time frame: Baseline, 9 weeks

  8. Change in digital health literacy as assessed by the Digital Health Care Literacy Scale

    The Digital Health Care Literacy scale is a 3-item questionnaire. Response options ranged from strongly disagree (0 points) to strongly agree (4 points). Total possible score options ranged from 0-12. Higher scores indicated higher digital health care literacy.

    Time frame: Baseline, 9 weeks

  9. Change in digital health literacy as assessed by the Mobile Device Proficiency Questionnaire (MDPQ)

    The MDPQ is a 16-item questionnaire divided into 8 sub-scales. All items are on a 5-point scale with choices never tried (1), not at all (2), not very easily (3), somewhat easily (4), and to very easily (5). A low score indicates low mobile device proficiency.

    Time frame: Baseline, 9 weeks

Secondary outcomes

  1. Change in Function as assessed by Lawton & Brody's assessment of Instrumental Activities of Daily Living Scale

    The assessment contains 8 questions with answers that are either a score of 0 or 1. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women, and 0 through 5 for men to avoid potential gender bias.

    Time frame: Baseline, 9 weeks

  2. Change in Function as assessed by the Katz Index of Independence in Activities of Daily Living

    6 questions, each 1 point for a total score of 6. A score closer to 6 indicates high patient independence.

    Time frame: Baseline, 9 weeks

  3. Change in Pain as assessed by the Brief Pain Inventory

    The Brief Pain Inventory - is a 4-item self-administered questionnaire used to evaluate the severity of a patient's pain and the impact of this pain on the patient's daily functioning. The patient is asked to rate their worst, least, average, and current pain intensity, list current treatments and their perceived effectiveness, and rate the degree that pain interferes with general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life on a 10 point scale. For the 10 point scale, 0 indicated no pain and 10 indicates the worst imaginable pain. Score range 0-40.

    Time frame: Baseline, 9 weeks

  4. Change in Depression as assessed by the Patient Health Questionnaire Depression Scale (PHQ-2)

    The PHQ-2 is a item self-reported questionnaire to assess frequency of depression. The total score ranges from 0-6. A score of 3 or greater signifies that major depressive disorder is likely.

    Time frame: Baseline, 9 weeks

  5. Change in Frailty as assessed by the Fried Frailty Phenotype

    The Fried Frailty Phenotype contains 5 criteria: unintentional weight loss \>10lbs \>5% of body mass in the last year, weakness (handgrip strength measurement), exhaustion (based on the Center for Epidemiological Studies Depression Scale), slow gait (walking time over a distance), and low physical activity. People who had none of the criteria were considered non-frail, people who had 1 and 2 criteria were considered pre-frail, and people who had ≥3 criteria were considered frail.

    Time frame: Baseline, 9 weeks

Other outcomes

  1. Acceptability at endpoint of intervention assessed by survey

    Score on Likert scale-based questions re: program content \& structure satisfaction, willingness to recommend. Survey developed by study team.

    Time frame: 9 weeks

  2. Feasibility as assessed by qualitative questions

    Open/ Close Ended Questions. Questions developed by study team.

    Time frame: 9 weeks

  3. Feasibility as assessed by recruitment rate

    Recruitment Rate. Measured by how many people recruited over designated period of time Mean time for survey administration, Withdrawal Rate, Cost. Questions developed by study team.

    Time frame: 9 weeks

  4. Feasibility as assessed by completion rate

    Measured by how many people complete the intervention over designated period of time

    Time frame: 9 weeks

  5. Feasibility as assessed by mean time for survey administration

    Mean time for survey administration measured by the average time it takes data collector to administer survey to participants

    Time frame: 9 weeks

  6. Feasibility as assessed by withdrawal rate

    Withdrawal Rate. Measured by how many people withdrawal from the intervention over designated period of time

    Time frame: 9 weeks

  7. Feasibility as assessed by average cost

    Cost. measured by average cost to deliver the intervention per person

    Time frame: 9 weeks

  8. Fidelity as assessed by percent completion of intervention items at endpoint of intervention

    % tasks/ patient- directed content delivery per session

    Time frame: through study completion, an average of 1.5 years

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2024 to primary completion in Mar 2026, 16 months.

Of 115 non-industry interventional studies with no phase under Literacy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 20. This study's 16 months is above that.

Counting every sponsor, half of 117 studies reached it within 11 months; a quarter within 4 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2024
First posted
Jun 28, 2024
StartActual
Nov 7, 2024
Primary completionActual
Mar 30, 2026
CompletionEst.
Dec 2026
Last update
Jul 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06479707
Responsible party
Sponsor
First posted
Jun 28, 2024
Start date
Nov 7, 2024
Primary completion
Mar 30, 2026
Completion
Dec 2026 (estimated)
Last update
Jul 2, 2026

Study contacts

Melissa Hladek, PhD
principal investigator · Johns Hopkins School of Nursing

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion